Notice of Registration - 2012
[Federal Register Volume 77, Number 24 (Monday, February 6, 2012)]
[Notices]
[Page 5849]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-2586]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated September 28, 2011, and published in the Federal
Register on October 7, 2011, 76 FR 62450, GE Healthcare, 3350 North
Ridge Avenue, Arlington Heights, Illinois 60004-1412, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of Cocaine (9041), a basic class of
controlled substance listed in schedule II.
The company plans to manufacture a radioactive product to diagnose
Parkinson's disease, and to manufacture a bulk investigational new drug
(IND) for clinical trials.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
GE Healthcare to manufacture the listed basic class of controlled
substance is consistent with the public interest at this time. DEA has
investigated GE Healthcare to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above
named company is granted registration as a bulk manufacturer of the
basic class of controlled substance listed.
Dated: January 26, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-2586 Filed 2-3-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
